Hepatocellular Carcinoma–Circulating Tumor Cells Expressing PD‐L1 Are Prognostic and Potentially Associated With Response to Checkpoint Inhibitors

Hepatocellular carcinoma (HCC) is a leading cause of mortality. Checkpoint inhibitors of programmed cell death protein‐1 (PD‐1) and programmed death‐ligand 1 (PD‐L1) have shown great efficacy, but lack biomarkers that predict response. Circulating tumor cells (CTCs) have promise as a liquid‐biopsy b...

Descripción completa

Detalles Bibliográficos
Autores principales: Winograd, Paul, Hou, Shuang, Court, Colin M., Lee, Yi‐Te, Chen, Pin‐Jung, Zhu, Yazhen, Sadeghi, Saeed, Finn, Richard S., Teng, Pai‐Chi, Wang, Jasmin J., Zhang, Zhicheng, Liu, Hongtao, Busuttil, Ronald W., Tomlinson, James S, Tseng, Hsian‐Rong, Agopian, Vatche G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527695/
https://www.ncbi.nlm.nih.gov/pubmed/33024921
http://dx.doi.org/10.1002/hep4.1577

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527695/
https://www.ncbi.nlm.nih.gov/pubmed/33024921
http://dx.doi.org/10.1002/hep4.1577

Ejemplares similares